The Food and Drug Administration (FDA) has added a boxed warning about liver injury to fezolinetant (Veozah), a drug often prescribed for hot flashes in menopausal women, according to an FDA statement ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback